Role of CD97 isoforms in gastric carcinoma

International Journal of Oncology

Volumn 36, Issue 6, 2010, Pages 1401-1408

  Liu, Daren ^a,b   Trojanowicz, Bogusz ^b   Radestock, Yvonne ^b   Fu, Ting ^b   Hammje, Kathrin ^b   Chen, Li ^a   Hoang Vu, Cuong ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

CD97; Gastric carcinoma; Isoform

Indexed keywords

CD97 ANTIGEN; ISOPROTEIN; TUBULIN;

ACETYLATION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; MOLECULAR CLONING; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTIGENS, CD; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION;

EID: 77951584093     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000625     Document Type: Article

References (22)

1. Martens GJ: Molecular biology of G-protein-coupled receptors. Prog Brain Res 92: 201-214, 1992.
2. Eichler W, Aust G and Hamann D: Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2). Scand J Immunol 39: 111-115, 1994. (Pubitemid 24232906)
3. Chang GW, Stacey M, Kwakkenbos MJ, Hamann J, Gordon S and Lin HH: Proteolytic cleavage of the EMR2 receptor requires both the extracellular stalk and the GPS motif. FEBS Lett 547: 145-150, 2003. (Pubitemid 36829395)
4. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U and Kelly K: CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157: 5438-5447, 1996. (Pubitemid 126448963)
5. Leemans JC, te Velde AA, Florquin S, Bennink RJ, De Bruin K, van Lier RA, van der Poll T and Hamann J: The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 172: 1125-1131, 2004.
6. Kwakkenbos MJ, Matmati M, Madsen O, Pouwels W, Wang Y, Bontrop RE, Heidt PJ, Hoek RM and Hamann J: An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2. FASEB J 20: 2582-2584, 2006.
7. Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, Hamann J and Aust G: Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol 161: 1657-1667, 2002 (Pubitemid 35265525)
8. Hamann J, Stortelers C, Kiss-Toth E, Vogel B, Eichler W and van Lier RA: Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur J Immunol 28: 1701-1707, 1998. (Pubitemid 28221175)
9. Lin HH, Stacey M, Saxby C, Knott V, Chaudhry Y, Evans D, Gordon S, McKnight AJ, Handford P and Lea S: Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex. J Biol Chem 276: 24160-24169, 2001. (Pubitemid 37410822)
10. Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, Aust G, Köhrle J and Dralle H: Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab 84: 1104-1109, 1999. (Pubitemid 29138250)
11. Jaspars LH, Vos W, Aust G, van Lier RA and Hamann J: Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 57: 325-331, 2001. (Pubitemid 32511301)
12. Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O, Scherbaum WA, Dralle H and Hoang-Vu C: CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798 - 1806, 1997.
13. Inoue T, Yamakawa M and Takahashi T: Expression of complement regulating factors in gastric cancer cells. Mol Pathol 55: 193-199, 2002. (Pubitemid 34620770)
14. Liu Y, Chen L, Peng SY, Chen ZX and Hoang-Vu C: Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. J Zhejiang Univ Sci B 6: 913-918, 2005. (Pubitemid 41443863)
15. Aust G, Steinert M, Schütz A, Boltze C, Wahlbuhl M, Hamann J and Wobus M: CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas. Am J Clin Pathol 118: 699-707, 2002. (Pubitemid 37046314)
16. Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, Loeffler M and Aust G: Individual cell-based models of tumor-environment interactions: multiple effects of CD97 on tumor invasion. Am J Pathol 169: 1802-1811, 2006.
17. Hensel F, Hermann R, Brändlein S, Krenn V, Schmausser B, Geis S, Müller-Hermelink HK and Vollmers HP: Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis. Lab Invest 81: 1553-1563, 2001. (Pubitemid 33064281)
18. Park KJ, Choi HJ, Roh MS, Kwon HC and Kim C: Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48: 1597-1602, 2005.
19. Nakanishi Y, Ochiai A, Kato H, Tachimori Y, Igaki H and Hirohashi S: Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer 91: 1114-1120, 2001. (Pubitemid 32295416)
20. Maruta H, Greer K and Rosenbaum JL: The acetylation of alpha-tubulin and its relationship to the assembly and disassembly of microtubules. J Cell Biol 103: 571-579, 1986. (Pubitemid 16055052)
21. Honore S, Kamath K, Braguer D, Wilson L, Briand C and Jordan MA: Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Mol Cancer Ther 2: 1303-1311, 2003.
22. Westermann S and Weber K: Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 4: 938-947, 2003. (Pubitemid 37493642)